VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1572697
Sex: F
Age: 43
State: OK

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: scratchy throat/felt like it was burning; eustachian tubes felt like they were clogged; puffy tongue; rash on her throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 21-Jan-2021 for Adverse event, at a dose of UNK dosage form and PREDNISONE for Adverse event, at a dose of 50 mg once a day. On 21-Jan-2021, THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. 13 minutes and 47 seconds after the injection while the patient was still in the waiting area, she had a scratchy throat and felt like it was on fire. The patient was brought to the emergency room and was given another Benadryl shot. The reaction abated after 2 hours. She was prescribed with Prednisone 50 mg once a day for five days as home medication. At the time of the call, patient claimed that she was fine.

Other Meds:

Current Illness:

ID: 1572698
Sex: F
Age: 66
State: FL

Vax Date: 01/12/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to the touch, like this arm has fever at the injection site; itching at the injectin site; redness area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Allergy to animals (cats and dogs), Grass allergy and Seafood allergy. Concomitant products included ZINC, ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) and VITAMIN D NOS for Vitamin supplementation, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) outcome was unknown. The patient did not take any concomitant medication on the day of vaccination and started taking them again the day before the reaction occurred. The patient suspected that it could be interaction between vaccine and iodine in the Synthroid and hence suspended it. This case was linked to MOD-2021-150632 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Reporter address, Allergy, dosage regimen, action taken updated

Other Meds: ZINC; VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]; VITAMIN D NOS; SYNTHROID

Current Illness: Allergy to animals (cats and dogs); Grass allergy; Penicillin allergy; Seafood allergy

ID: 1572699
Sex: F
Age: 55
State: TX

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; fingers were hurting from cold; fingers were hurting from cold; can't call them chills, but her body temperature got really low; feels too weak; broke into a fever and got to 101.4 F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold), PYREXIA (broke into a fever and got to 101.4 F) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low). On 22-Jan-2021 at 9:15 AM, the patient experienced MYALGIA (Body aches). On 22-Jan-2021, MYALGIA (Body aches), PERIPHERAL COLDNESS (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) had resolved, PAIN IN EXTREMITY (fingers were hurting from cold) outcome was unknown. At the time of the report, FATIGUE (feels too weak) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.4 (High) 101.4 degree Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. 15 minutes later to the vaccination, at 7.32, the patient left the clinic and was still good, until 9.15 the day of report, when she got body aches. At 9.40 she experienced "can't call them chills, but her body temperature got really low", her fingers were hurting from cold. At 10.30 she broke into a fever and got to 101.4?F.

Other Meds:

Current Illness:

ID: 1572700
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 21-Jan-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1572701
Sex: F
Age: 89
State: NC

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: crying that her heel was hurting so bad; toes were less-colored, white, pale (different from other foot); This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Pains in legs. Concomitant products included OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication. On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)). The patient was treated with MAGNESIUM SULFATE (EPSOM SALTS [MAGNESIUM SULFATE]) (topical) on 22-Jan-2021 for Adverse event, at a dose of UNK dosage form (took epsom salt bath). At the time of the report, CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: OXYCONTIN

Current Illness: Pains in legs

ID: 1572702
Sex: M
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: face iitchy; Rash in his face and whole body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient had no known allergies before. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (Rash in his face and whole body) and PRURITUS (face iitchy ). At the time of the report, RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1572703
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: large urticarial wheel at the site of the injection; Very itchy at injection site; Very red at the injetion site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. The large urticarial wheal at the site of injection had extended since 21-Jan-2021. It was about 4 inches in length and 1 inch in width and was very itchy. At the time of report it was somewhat itchy after a dose of Benadryl.

Other Meds:

Current Illness:

ID: 1572704
Sex: F
Age:
State: VT

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Temperature was 101,temperature was recorded 101.8; arm tender; little swelling on neck; woke up feeling bad; had stomach upset; felt nauseous; vomited; felt chilled and shivering significantly; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous) and VOMITING (vomited) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug hypersensitivity. Concomitant products included IRON for Iron supplementation. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced FEELING ABNORMAL (woke up feeling bad), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset). On an unknown date, the patient experienced TENDERNESS (arm tender) and SWELLING (little swelling on neck). The patient was treated with PARACETAMOL (TYLENOL) on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form and IBUPROFEN on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form (on empty stomach). At the time of the report, FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Body temperature: 99.1 f (High) 99.1 F. On 20-Jan-2021, Body temperature: 101 f (High) Around 4 PM , 101.8 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: IRON

Current Illness: Drug hypersensitivity

ID: 1572705
Sex: F
Age:
State: NY

Vax Date: 01/15/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Elevated white blood cells count; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 21-Jan-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count). At the time of the report, WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, White blood cell count: elevated (High) elevated. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572706
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt a little tingling after the injection; couldn't lift up her arm; arm was sore; massive pain in arm not just injection site, whole shoulder area; lots of vomiting; 2 lymph nodes in the left armpit; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting) and LYMPHADENOPATHY (2 lymph nodes in the left armpit) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches). At the time of the report, PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: pending result (Inconclusive) pending result (to rule out breast cancer). On an unknown date, Ultrasound scan: lymph node (Inconclusive) lymph node. On an unknown date, X-ray: lymph node (Inconclusive) lymph node. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. After 5 hours, the patient had such massive pain in her arm, not just the injection site, it was the whole shoulder area. She couldn't lift up her arm to put on her bra; she was guessing it was because the lymph nodes swelling up so bad.

Other Meds:

Current Illness:

ID: 1572707
Sex: F
Age: 79
State: TX

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it felt like it was a little lumpy at the injection site; itchy and red at injection site; itchy and red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. On 23-Jan-2021 feeling much better; it was faded a lot. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572708
Sex: F
Age: 79
State: FL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle spasms on legs - "big time"; Spine pain; Joint pain; headaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) in January 2021 for Adverse event, at a dose of UNK dosage form. On 15-Jan-2021, MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Symptoms lasted about 3 days and she only took Tylenol.

Other Meds:

Current Illness:

ID: 1572709
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness in her fingers; numbness in her cheeks; weak; sore throat; exhausted; headache; muscle pain; some nausea; fever of 101.5; severe chills; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) 101.5. Concomitant medication was not reported. Treatment medication was not reported. The patient had vaccination at 08:40 AM and experienced the events at 08:50 AM on 21-Jan-2021.

Other Meds:

Current Illness:

ID: 1572710
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: halo pink looking sore around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. This case was linked to MOD-2021-013074 (Patient Link).

Other Meds:

Current Illness:

ID: 1572711
Sex: F
Age: 81
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy; Tiered; Joint Pain; Chills; Fever 103 F; muscle pain; Injection Site was a little Red; Injection Site was a little Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection Site was a little Red), VACCINATION SITE PAIN (Injection Site was a little Sore), MYALGIA (Achy), FATIGUE (Tiered) and ARTHRALGIA (Joint Pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (survived) in April 2020. On 21-Jan-2021 at 11:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore). On 22-Jan-2021, the patient experienced MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 103 F) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) on 22-Jan-2021 for Fever, at a dose of 500 milligram three times a day. On 22-Jan-2021, VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore) had resolved. At the time of the report, MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills) and MYALGIA (muscle pain) had not resolved and PYREXIA (Fever 103 F) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 103 f (High) 103 F and 101.2 f (High) After taking Tylenol went down to 101.2 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported.

Other Meds:

Current Illness:

ID: 1572712
Sex: F
Age:
State: IL

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling in the arm on the site of injection; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE SWELLING (swelling in the arm on the site of injection), INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (swelling in the arm on the site of injection). 21-Jan-2021, the patient experienced INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.). At the time of the report, INJECTION SITE SWELLING (swelling in the arm on the site of injection), INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no concomitant medication provided. no treatment given

Other Meds:

Current Illness:

ID: 1572713
Sex: F
Age: 76
State: CA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red and warm reaction at the injection site; red and warm reaction at the injection site; mild soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (mild soreness at the injection site), INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No prior medical history reported). On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced INJECTION SITE PAIN (mild soreness at the injection site). On 23-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site). On 11-Jan-2021, INJECTION SITE PAIN (mild soreness at the injection site) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. no concomitant medication provided no treatment taken

Other Meds:

Current Illness:

ID: 1572714
Sex: F
Age: 65
State: CA

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 2 roundish hives at injection site; tenderness; shoulder started to itch at injection site; red rash; swelling at injection site; sore arm/ pain; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (sore arm/ pain), INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Dermatitis due to metals since an unknown date. Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for Dermatitis. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (sore arm/ pain). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash) and INJECTION SITE SWELLING (swelling at injection site). On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced INJECTION SITE URTICARIA (2 roundish hives at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash and Itch, at an unspecified dose and frequency. In January 2021, VACCINATION SITE PAIN (sore arm/ pain) outcome was unknown. On 22-Jan-2021, TENDERNESS (tenderness) had resolved. At the time of the report, INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds: PREMARIN

Current Illness: Dermatitis due to metals

ID: 1572715
Sex: F
Age: 58
State: NY

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Positive covid test after 1st dose; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid test after 1st dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history). On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Jan-2021, the patient experienced COVID-19 (Positive covid test after 1st dose). At the time of the report, COVID-19 (Positive covid test after 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication and treatment information provided

Other Meds:

Current Illness:

ID: 1572716
Sex: M
Age: 77
State: KS

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweats; Coughs a lot; Feels like when you have the flu; No appetite; Big rash on the injection site; Chills; Itches a bit at injection site; Redness of the arm at injection site; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite) and VACCINATION SITE RASH (Big rash on the injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included High cholesterol. Concurrent medical conditions included Seasonal allergy. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site). At the time of the report, HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no concomitant medication provided patient has taken cough syrup but unknown

Other Meds:

Current Illness: Seasonal allergy

ID: 1572717
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bump in her arm; This spontaneous case was reported by a consumer and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no concomitant medication provided no treatment taken

Other Meds:

Current Illness:

ID: 1572718
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Urticaria at injection site; Injection site itchy; Injection site rash; Injection site redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) for Rash, Itchy and Urticaria, at an unspecified dose and frequency. At the time of the report, INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication provided

Other Meds:

Current Illness:

ID: 1572719
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; Weakness; Anxious; This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious). At the time of the report, DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no concomitant medication provided no treatment taken

Other Meds:

Current Illness:

ID: 1572720
Sex: F
Age: 57
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red; hard; cellulitis at the injection site; hot; tender; itchy; This spontaneous case was reported by a patient and describes the occurrence of SKIN WARM (hot), PAIN OF SKIN (tender), PRURITUS (itchy), ERYTHEMA (red) and INDURATION (hard) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SKIN WARM (hot), PAIN OF SKIN (tender) and PRURITUS (itchy). On 22-Jan-2021, the patient experienced ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site). On 15-Jan-2021, PAIN OF SKIN (tender) had resolved. At the time of the report, SKIN WARM (hot), ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site) outcome was unknown and PRURITUS (itchy) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient went to urgent care after her symptoms returned and started worsening. They diagnosed her with cellulitis at the injection site and prescribed her Bactrim topical ointment and doxycycline oral. Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Additional information included further details regarding the events, and additional patient information.

Other Meds:

Current Illness:

ID: 1572721
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Urticaria; injection site was very itchy; dark red rash; dark red rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Urticaria) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Urticaria). At the time of the report, URTICARIA (Urticaria) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Topical antihistamines were recommended as treatment.

Other Meds:

Current Illness:

ID: 1572722
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I felt like I had covid again; A whole night of not sleeping; Head hurt; My body hurt; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt). At the time of the report, VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572723
Sex: F
Age: 66
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle tightness in my shoulder up to my neck; She experienced numbness on her face in the cheek and bottom part of her chin; coolness in her mouth; experienced burning in her throat; light burning in her chest; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck), HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021 at 11:39 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck), HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest). On 21-Jan-2021, HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest) had resolved. On 22-Jan-2021, MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572724
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dark red rash that was very itchy; dark red rash that was very itchy; itchy; Skin peeling at injection site; This spontaneous case was reported by a nurse and describes the occurrence of in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient was recommended to use a topical antihistamine for treatment of the events.

Other Meds:

Current Illness:

ID: 1572725
Sex: F
Age: 67
State: TX

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little bit of tingling in both arms; Little bit of soreness in arm; Warm; Slight headache; Fever; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LOSARTAN, ROSUVASTATIN and OXYBUTYNIN for an unknown indication. On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever). At the time of the report, PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: LOSARTAN; ROSUVASTATIN; OXYBUTYNIN

Current Illness:

ID: 1572726
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got rash 3 days after the vaccine; This spontaneous case was reported by a patient and describes the occurrence of RASH (Got rash 3 days after the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Got rash 3 days after the vaccine). At the time of the report, RASH (Got rash 3 days after the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572727
Sex: M
Age: 26
State: NY

Vax Date: 01/09/2021
Onset Date: 01/17/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Found out he had COVID; Runny nose; Stuffy and runny nose; Sneezing; Stuffy and runny nose; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing) and RHINORRHOEA (Stuffy and runny nose) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 102L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Found out he had COVID) outcome was unknown and RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Date of the test is not provided. and negative (Negative) Date of the test is not provided.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. The patient took emergenC for treatment of the events.

Other Meds:

Current Illness:

ID: 1572728
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Migraine; This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient did not receive any treatment.

Other Meds:

Current Illness:

ID: 1572729
Sex: F
Age: 28
State: IL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling in the arm; Pain/ hurt a lot; Can't move arm; Panicking as never got pain like this; Chills; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Panicking as never got pain like this) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 126L20A) for COVID-19 vaccination. No medical history was provided. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 21-Jan-2021 at 5:55 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ANXIETY (Panicking as never got pain like this). At the time of the report, ANXIETY (Panicking as never got pain like this) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: TYLENOL

Current Illness:

ID: 1572730
Sex: F
Age: 42
State: NY

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to the touch at the injection site; red; Swelling; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient sought treatment from a doctor and she was prescribed cephalexin, but had not started taking it at the time of this report.

Other Meds:

Current Illness:

ID: 1572731
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/19/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hives on 12th dayand 15th day after vaccine; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (hives on 12th dayand 15th day after vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced URTICARIA (hives on 12th dayand 15th day after vaccine). At the time of the report, URTICARIA (hives on 12th dayand 15th day after vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572732
Sex: F
Age: 53
State: NJ

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rapid heartbeat around 120; diarrhea; low-grade fever; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting). At the time of the report, TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: around 120 High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572733
Sex: F
Age: 43
State:

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling face, mouth, lips; swelling of face, tongue; Itching; From my lips and left ear, down my jaw I am numb; face and neck turned red/hand are itching and red; hives all over body; Allergic reaction; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb) and ERYTHEMA (face and neck turned red/hand are itching and red) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient was given Benadryl after the initial onset of the events. 5 hours after taking Benadryl, the events returned and the patient took another dose of Benadryl.

Other Meds:

Current Illness:

ID: 1572734
Sex: F
Age: 73
State: GA

Vax Date: 01/20/2021
Onset Date: 02/01/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching; Redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Redness on the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Redness on the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH RELIEF) (topical) at a dose of UNK dosage form. On 03-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness on the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Additional information received, provides outcome of the event and second dosage information was updated.

Other Meds:

Current Illness:

ID: 1572735
Sex: M
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: His arm was hurting real bad.; sleepy; He felt real tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired). At the time of the report, PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572736
Sex: F
Age: 70
State:

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Spots on back; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (Spots on back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Lupus erythematosus. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced RASH MACULAR (Spots on back). At the time of the report, RASH MACULAR (Spots on back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient used an unspecified steroid cream as treatment for the event.

Other Meds:

Current Illness: Lupus erythematosus

ID: 1572737
Sex: F
Age: 72
State: IN

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash below the injection site; Soreness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 28-Jan-2021 for Vaccination site rash and Vaccination site pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1572738
Sex: F
Age: 71
State: WA

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site pain; Redness; Swelling; Fever; Fatigue; Aches; Chills; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided. Concomitant products included LISINOPRIL for an unknown indication. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills) outcome was unknown. No treatment information was provided.

Other Meds: LISINOPRIL

Current Illness:

ID: 1572739
Sex: F
Age:
State: TX

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea; Severe muscle and joint pain; Severe muscle and joint pain; Fever; Headache; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 (took 5 weeks to have negative covid test) and Pneumonia (2 months ago). Concurrent medical conditions included Iodine allergy, Blood pressure high and Vascular disorder NOS. Concomitant products included ATENOLOL for Blood pressure high. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) on 22-Jan-2021 at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: systolic 170 High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ATENOLOL

Current Illness: Blood pressure high; Iodine allergy; Vascular disorder NOS

ID: 1572740
Sex: F
Age: 33
State: CA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes on left side of neck; Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain; Exposure during breast feeding; Dizziness; Arm pain; This spontaneous case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding), DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm pain), LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) and LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding), DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Arm pain). On 13-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) and LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain). On 11-Jan-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding) had resolved. On 12-Jan-2021, DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Arm pain) had resolved. On 14-Jan-2021, LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-013243 (Parent-Child Link). See case MOD-2021-013243 for details regarding the child case.

Other Meds:

Current Illness:

ID: 1572741
Sex: F
Age: 66
State: FL

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chest Pain; Bad sweat from head to toe; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Chest Pain) and HYPERHIDROSIS (Bad sweat from head to toe) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERHIDROSIS (Bad sweat from head to toe). On an unknown date, the patient experienced CHEST PAIN (Chest Pain). At the time of the report, CHEST PAIN (Chest Pain) and HYPERHIDROSIS (Bad sweat from head to toe) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572742
Sex: F
Age: 40
State: WI

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flushing; Itching; This spontaneous case was reported by an other health care professional and describes the occurrence of FLUSHING (Flushing) and PRURITUS (Itching) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included Migraine. Concurrent medical conditions included Hyperlipidemia, Penicillin allergy and Drug allergy (Sulfa allergy). Concomitant products included EPINEPHRINE and DEXAMETHASONE for an unknown indication. On 29-Jan-2021 at 4:55 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021 at 5:00 PM, the patient experienced FLUSHING (Flushing) and PRURITUS (Itching). At the time of the report, FLUSHING (Flushing) and PRURITUS (Itching) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient was reported to receive epinephrine and dexamethasone in the clinic prior to arrival. Patient was reported to be treated with intravenous fluids, dose of corticosteroids and H1 and H2 blockers in the emergency department. On discharge, he patient was asked to continue Benadryl (diphenhydramine hydrochloride) if needed. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.

Other Meds: EPINEPHRINE; DEXAMETHASONE

Current Illness: Drug allergy (Sulfa allergy); Hyperlipidemia; Penicillin allergy

ID: 1572743
Sex: F
Age: 70
State: CO

Vax Date: 01/11/2021
Onset Date: 01/18/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itch around injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (itch around injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itch around injection site). At the time of the report, VACCINATION SITE PRURITUS (itch around injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. The patient did not receive any treatment for the event. Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI

Other Meds:

Current Illness:

ID: 1572744
Sex: F
Age: 95
State:

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat; sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1572745
Sex: F
Age: 69
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea comes and goes; Heavy nightmares; Palpitations; Body has felt a little off; Bad headaches; Arm felt heavy and painful; Arm felt heavy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and PAIN IN EXTREMITY (Arm felt heavy and painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Penicillin allergy, Drug allergy (darvacet and darvan.) and Blood pressure high. Concomitant products included LOSARTAN, VITAMIN D3 and CORTISONE for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy) and PYREXIA (Fever). On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and HEADACHE (Bad headaches). At the time of the report, DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off), PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy), PYREXIA (Fever) and HEADACHE (Bad headaches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds: LOSARTAN; VITAMIN D3; CORTISONE

Current Illness:

ID: 1572746
Sex: F
Age: 57
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling sensation that went up her neck and onto her cheek; tingling sensation that was itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. Concomitant products included ATORVASTATIN and VITAMINS NOS for an unknown indication. On 21-Jan-2021 at 4:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021 at 8:00 PM, the patient experienced PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy). At the time of the report, PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Treatment details provided for the patient were-on 21Jan2021 patient took loratadine and on 22Jan2021- patient took diphenhydramine.

Other Meds: ATORVASTATIN; VITAMINS NOS

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm